Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription Articles published in Heart Retrieve available abstracts of 73 articles: HTML format

Single Articles

October 2025
1. KYLHAMMAR A, Tsartsalis D, Hijazi Z, Aggeli C, et al
   Risk and protective factors for stroke and transient ischaemic attack in patients with atrial fibrillation: an umbrella review of meta-analyses.
   Heart. 2025 Oct 7:heartjnl-2025-325926. doi: 10.1136/heartjnl-2025-325926.
   PubMed     Abstract available
   
   
   
2. BALLATORE A, Griffith Brookles C, O'Neill M, Saglietto A, et al
   Beyond recurrence: redefining atrial fibrillation burden as a prognostic and therapeutic endpoint.
   Heart. 2025 Oct 7:heartjnl-2025-325779. doi: 10.1136/heartjnl-2025-325779.
   PubMed     Abstract available
   
   
   
3. LINZ D, Chaldoupi SM
   Broadening the concept of 'burden' from the assessment of arrhythmias to symptom evaluation in patients with atrial fibrillation.
   Heart. 2025 Oct 7:heartjnl-2025-326551. doi: 10.1136/heartjnl-2025-326551.
   PubMed    
   
   
   
4. KILIC ME, Arayici ME, Yilancioglu RY, Turan OE, et al
   Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis.
   Heart. 2025 Oct 6:heartjnl-2025-326174. doi: 10.1136/heartjnl-2025-326174.
   PubMed     Abstract available
   
   
   September 2025
5. YANG S, De Kruijf N, Zhu F, van Oortmerssen JAE, et al
   Trends in burden of atrial fibrillation over three decades: a population-based study.
   Heart. 2025 Sep 27:heartjnl-2025-326510. doi: 10.1136/heartjnl-2025-326510.
   PubMed     Abstract available
   
   
   
6. MU L, Larvin H, Nadarajah R, Gale CP, et al
   Long-term cardiovascular risks after atrial fibrillation diagnosis: a systematic review and meta-analysis.
   Heart. 2025 Sep 17:heartjnl-2025-326376. doi: 10.1136/heartjnl-2025-326376.
   PubMed     Abstract available
   
   
   
7. CHO MS, Kang DY, Lee JB, Oh YS, et al
   Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial.
   Heart. 2025 Sep 9:heartjnl-2025-326646. doi: 10.1136/heartjnl-2025-326646.
   PubMed     Abstract available
   
   
   
8. WILNES B, Castello-Branco B, Santangeli P
   ECG algorithms for localisation of outflow tract ventricular arrhythmias: is there a winner?
   Heart. 2025 Sep 3:heartjnl-2025-326550. doi: 10.1136/heartjnl-2025-326550.
   PubMed    
   
   
   August 2025
9. TSURUMI H, Kusunose K
   Atrial fibrillation in chronic aortic regurgitation: the missing link in prognosis and surgical timing.
   Heart. 2025 Aug 11:heartjnl-2025-326727. doi: 10.1136/heartjnl-2025-326727.
   PubMed    
   
   
   
10. FRANCISCO-PASCUAL J, Rajjoub K
    Premature ventricular complex, atrial fibrillation and stroke: causality or coincidence?
    Heart. 2025 Aug 7:heartjnl-2025-326530. doi: 10.1136/heartjnl-2025-326530.
    PubMed    
    
    
    July 2025
11. QIN P, Ho FK, Celis-Morales CA, Trost SG, et al
    Association of self-reported and accelerometer-based walking pace with incident cardiac arrhythmias: a prospective cohort study using UK Biobank.
    Heart. 2025;111:763-768.
    PubMed     Abstract available
    
    
    
12. AL-HUSSAINY N, Kragholm K, Lundbye-Christensen S, Torp-Pedersen C, et al
    Timing of anticoagulation restart after serious bleeding in atrial fibrillation.
    Heart. 2025 Jul 16:heartjnl-2024-325343. doi: 10.1136/heartjnl-2024-325343.
    PubMed     Abstract available
    
    
    
13. PUGLIESI GM, Scott CG, Nkomo VT, Michelena HI, et al
    Prevalence and prognostic role of atrial fibrillation in chronic severe aortic regurgitation.
    Heart. 2025 Jul 16:heartjnl-2025-325823. doi: 10.1136/heartjnl-2025-325823.
    PubMed     Abstract available
    
    
    
14. RANKINEN J, Hernesniemi J, Tynkkynen JT
    Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications.
    Heart. 2025 Jul 15:heartjnl-2025-326003. doi: 10.1136/heartjnl-2025-326003.
    PubMed     Abstract available
    
    
    
15. ARJAMAA O
    Rethinking natriuretic peptides: hypoxia and haemoconcentration in atrial fibrillation.
    Heart. 2025 Jul 14:heartjnl-2025-326327. doi: 10.1136/heartjnl-2025-326327.
    PubMed    
    
    
    
16. HE Z, Liu M, Ying P, Song M, et al
    Diagnostic accuracy of electrocardiogram algorithms for differentiating left from right outflow tract ventricular arrhythmia: a systematic review and network meta-analysis.
    Heart. 2025 Jul 3:heartjnl-2025-325916. doi: 10.1136/heartjnl-2025-325916.
    PubMed     Abstract available
    
    
    June 2025
17. FERRARI F, da Silveira AD, Rossi AP, Pedrotti LG, et al
    Distinct early repolarisation patterns in male Brazilian soccer players: insights from a multicentre study.
    Heart. 2025;111:657-661.
    PubMed     Abstract available
    
    
    
18. BOULEAU R, Glaser N, Jonsson M, Scorza R, et al
    Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease.
    Heart. 2025 Jun 23:heartjnl-2024-325322. doi: 10.1136/heartjnl-2024-325322.
    PubMed     Abstract available
    
    
    
19. ZHANG J, Chen G, Wei S, Li W, et al
    Impact of air pollution and multimorbidity on the risk of incident atrial fibrillation.
    Heart. 2025 Jun 19:heartjnl-2024-325451. doi: 10.1136/heartjnl-2024-325451.
    PubMed     Abstract available
    
    
    May 2025
20. SONG Z, Wang SY, Qidong Z, Chen N, et al
    Catheter ablation versus medical rate control for persistent atrial fibrillation in older heart failure patients with reduced ejection fraction.
    Heart. 2025 May 20:heartjnl-2024-324668. doi: 10.1136/heartjnl-2024-324668.
    PubMed     Abstract available
    
    
    April 2025
21. BECHER N, Metzner A, Kirchhof P
    Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AF.
    Heart. 2025 Apr 29:heartjnl-2024-324848. doi: 10.1136/heartjnl-2024-324848.
    PubMed     Abstract available
    
    
    
22. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    PubMed     Abstract available
    
    
    
23. KALRA PR, Ford I
    Iron deficiency in patients with atrial fibrillation: moving towards a treatment target?
    Heart. 2025 Apr 4:heartjnl-2025-325755. doi: 10.1136/heartjnl-2025-325755.
    PubMed    
    
    
    March 2025
24. ECONOMOU LUNDEBERG J, Wuopio J, Mente A, Maneheim A, et al
    Estimated sodium intake and premature ventricular complexes: data from the population-based Swedish CArdioPulmonary bioImage Study.
    Heart. 2025;111:300-305.
    PubMed     Abstract available
    
    
    
25. DOWNES TJ, Guthrie B, Moreno-Martos D, Morales DR, et al
    Health conditions in adults with atrial fibrillation compared with the general population: a population-based cross-sectional analysis.
    Heart. 2025 Mar 4:heartjnl-2024-324618. doi: 10.1136/heartjnl-2024-324618.
    PubMed     Abstract available
    
    
    February 2025
26. MITCHELL A, Watson MC, Welsh TJ, McGrogan A, et al
    Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods.
    Heart. 2025 Feb 17:heartjnl-2024-324763. doi: 10.1136/heartjnl-2024-324763.
    PubMed     Abstract available
    
    
    
27. MOHAMED AA, Christensen DM, Mohammad M, Torp-Pedersen C, et al
    Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failure.
    Heart. 2025 Feb 8:heartjnl-2024-325244. doi: 10.1136/heartjnl-2024-325244.
    PubMed     Abstract available
    
    
    
28. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    PubMed     Abstract available
    
    
    January 2025
29. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    PubMed     Abstract available
    
    
    
30. ABDALI Z, Bunting KV, Mehta S, Camm J, et al
    Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial.
    Heart. 2025 Jan 16:heartjnl-2024-324761. doi: 10.1136/heartjnl-2024-324761.
    PubMed     Abstract available
    
    
    December 2024
31. LEMOINE MD, Fabritz L
    Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants.
    Heart. 2024 Dec 18:heartjnl-2024-325242. doi: 10.1136/heartjnl-2024-325242.
    PubMed    
    
    
    
32. MANNION J, Murray C, Wilkinson M
    Unresponsive patient with bradycardia.
    Heart. 2024;111:17-44.
    PubMed    
    
    
    
33. WANG W, Zhou T, Li J, Yuan C, et al
    Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies.
    Heart. 2024 Dec 6:heartjnl-2024-324685. doi: 10.1136/heartjnl-2024-324685.
    PubMed     Abstract available
    
    
    November 2024
34. CEELEN DCH, Bracun V, van Essen BJ, Voors AA, et al
    Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure.
    Heart. 2024 Nov 29:heartjnl-2024-324486. doi: 10.1136/heartjnl-2024-324486.
    PubMed     Abstract available
    
    
    
35. KAPOOR K, Lloyd MS
    Handing over the car keys: a reappraisal of driving restrictions after implantable cardioverter/defibrillator implantation.
    Heart. 2024;110:1391-1392.
    PubMed    
    
    
    
36. AHMAD S, Straw S, Gierula J, Roberts E, et al
    Optimising remote monitoring for cardiac implantable electronic devices: a UK Delphi consensus.
    Heart. 2024;110:1357-1364.
    PubMed     Abstract available
    
    
    
37. LAUWERS C, Troost E, De Meester P, Moons P, et al
    Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study.
    Heart. 2024 Nov 7:heartjnl-2024-324417. doi: 10.1136/heartjnl-2024-324417.
    PubMed     Abstract available
    
    
    
38. TRINCADO AVE M, Brion M, Blanco-Verea A, Tilves C, et al
    Prevalence and relevance of H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.
    Heart. 2024 Nov 1:heartjnl-2024-324506. doi: 10.1136/heartjnl-2024-324506.
    PubMed     Abstract available
    
    
    October 2024
39. TAHA A, Martinsson A, Nielsen SJ, Rezk M, et al
    New-onset atrial fibrillation after coronary surgery and stroke risk: a nationwide cohort study.
    Heart. 2024 Oct 4:heartjnl-2024-324573. doi: 10.1136/heartjnl-2024-324573.
    PubMed     Abstract available
    
    
    September 2024
40. CEN H, Chen S, Sun P
    A rare case of atrial flutter and a cystic mass in the left atrium.
    Heart. 2024;110:1207-1242.
    PubMed    
    
    
    
41. MILLS MT, McDowell G, Lip GYH
    Predicting future atrial fibrillation: risk factors, proteomics and beyond.
    Heart. 2024 Sep 11:heartjnl-2024-324954. doi: 10.1136/heartjnl-2024-324954.
    PubMed    
    
    
    
42. LIU M, Zhang Y, Ye Z, He P, et al
    Enhanced prediction of atrial fibrillation risk using proteomic markers: a comparative analysis with clinical and polygenic risk scores.
    Heart. 2024 Sep 4:heartjnl-2024-324274. doi: 10.1136/heartjnl-2024-324274.
    PubMed     Abstract available
    
    
    August 2024
43. KOLDENHOF T, Van Gelder IC, van de Lande ME, Al-Jazairi MIH, et al
    High heart rates during paroxysmal atrial fibrillation: continuous rhythm monitoring data of the RACE V study.
    Heart. 2024 Aug 21:heartjnl-2024-324376. doi: 10.1136/heartjnl-2024-324376.
    PubMed     Abstract available
    
    
    
44. WONG CK, Lau YM, Lui HW, Chan WF, et al
    Automatic detection of cardiac conditions from photos of electrocardiogram captured by smartphones.
    Heart. 2024;110:1074-1082.
    PubMed     Abstract available
    
    
    July 2024
45. PAPANASTASIOU CA, Bazmpani MA, Kampaktsis PN, Zegkos T, et al
    Cardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis.
    Heart. 2024 Jul 30:heartjnl-2024-324182. doi: 10.1136/heartjnl-2024-324182.
    PubMed     Abstract available
    
    
    June 2024
46. FRAUSING MHJP, Van De Lande M, Linz D, Crijns HJGM, et al
    Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration.
    Heart. 2024 Jun 29:heartjnl-2024-324016. doi: 10.1136/heartjnl-2024-324016.
    PubMed     Abstract available
    
    
    
47. PARISI EJ, Chung EH
    Palpitations in athletes: diagnosis, workup and treatment.
    Heart. 2024;110:963-969.
    PubMed     Abstract available
    
    
    
48. ALBERTINI L, Spears DA
    Management of arrythmias during pregnancy.
    Heart. 2024;110:916-925.
    PubMed    
    
    
    May 2024
49. GALLAGHER C, Wilson G, Lau DH
    Microvascular disease and arrhythmias: a renewed focus on the myocardial microvasculature?
    Heart. 2024;110:755-756.
    PubMed    
    
    
    
50. CHEN GC, Nyarko Hukportie D, Fan WD, Lyu JQ, et al
    Microvascular disease, modifiable risk factor profiles and incident arrhythmias in type 2 diabetes.
    Heart. 2024;110:776-782.
    PubMed     Abstract available
    
    
    March 2024
51. SOORAMPALLY V, Veeraraghavan S, Kidambi BR
    Dyspnoea, dizziness and dysrhythmia in a middle-aged patient.
    Heart. 2024;110:559-614.
    PubMed    
    
    
    
52. ISHIKITA A, McIntosh C, Roche SL, Barron DJ, et al
    Incremental value of machine learning for risk prediction in tetralogy of Fallot.
    Heart. 2024;110:560-568.
    PubMed     Abstract available
    
    
    
53. VINTER N, Cordsen P, Johnsen SP, Benjamin EJ, et al
    Birth cohort effects on diagnosed atrial fibrillation incidence: nationwide cohort study from 1980 to 2018.
    Heart. 2024 Mar 12:heartjnl-2023-323737. doi: 10.1136/heartjnl-2023-323737.
    PubMed     Abstract available
    
    
    
54. SAMUEL M, Rienstra M
    Birth cohort effect in atrial fibrillation: a matter of detection?
    Heart. 2024 Mar 12:heartjnl-2024-323950. doi: 10.1136/heartjnl-2024-323950.
    PubMed    
    
    
    February 2024
55. KAMSANI SH, Middeldorp ME
    Adherence in a fortnight: is this a true reflection of a lifetime?
    Heart. 2024 Feb 8:heartjnl-2023-323800. doi: 10.1136/heartjnl-2023-323800.
    PubMed    
    
    
    January 2024
56. VAN HATTUM JC, Daems JJN, Verwijs SM, Wismans LV, et al
    Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
    Heart. 2024;110:254-262.
    PubMed     Abstract available
    
    
    
57. LAMBIASE PD
    Determining risk of sudden death: is it all in the T wave?
    Heart. 2024;110:151-153.
    PubMed    
    
    
    
58. HNATKOVA K, Andrsova I, Novotny T, Vanderberk B, et al
    QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators.
    Heart. 2024;110:178-187.
    PubMed     Abstract available
    
    
    
59. MAASS AH
    Inequities in access and use of automated external defibrillators.
    Heart. 2024;110:154-155.
    PubMed    
    
    
    
60. VAN DER VELDEN RMJ, Bonander C, Crijns HJGM, Kemp-Gudmundsdottir K, et al
    Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes.
    Heart. 2024 Jan 5:heartjnl-2023-323522. doi: 10.1136/heartjnl-2023-323522.
    PubMed     Abstract available
    
    
    December 2023
61. JOHANSSON M, Fedorowski A
    Situational vs vasovagal syncope: one but different?
    Heart. 2023;110:3-4.
    PubMed    
    
    
    
62. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available
    
    
    November 2023
63. FREDERIKSEN TC, Christiansen MK, Benjamin EJ, Overvad K, et al
    Interaction of genetic risk and lifestyle on the incidence of atrial fibrillation.
    Heart. 2023 Nov 28:heartjnl-2023-323333. doi: 10.1136/heartjnl-2023-323333.
    PubMed     Abstract available
    
    
    
64. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    PubMed     Abstract available
    
    
    
65. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available
    
    
    
66. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available
    
    
    
67. OTTO CM
    Heartbeat: atrial fibrillation phenotyping identifies patients at high risk of adverse events.
    Heart. 2023;109:1725-1726.
    PubMed    
    
    
    October 2023
68. OTTO CM
    Heartbeat: ultra-processed foods and atrial fibrillation risk.
    Heart. 2023;109:1651-1653.
    PubMed    
    
    
    
69. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    PubMed     Abstract available
    
    
    
70. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available
    
    
    
71. TEIGER E, Eschalier R, Amabile N, Rioufol G, et al
    Left atrial appendage closure in very elderly patients in the French National Registry.
    Heart. 2023 Oct 9:heartjnl-2023-322871. doi: 10.1136/heartjnl-2023-322871.
    PubMed     Abstract available
    
    
    September 2023
72. LOPEZ-LIZARRAGA MA, Sanchez-Amaya DJ, Godinez-Cordova LB
    Paradoxical worsening of an arrhythmia due to antiarrhythmics.
    Heart. 2023;109:1515-1576.
    PubMed    
    
    
    
73. AKERSTROM F, Hutter J, Charitakis E, Tabrizi F, et al
    Association between catheter ablation of atrial fibrillation and mortality or stroke.
    Heart. 2023 Sep 1:heartjnl-2023-322883. doi: 10.1136/heartjnl-2023-322883.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.